Evidence map›Paper›PMID 20142487›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2010

Small-molecule screen identifies reactive oxygen species as key regulators of neutrophil chemotaxis.

Hidenori Hattori, Kulandayan K Subramanian, Jiro Sakai, Yonghui Jia, Yitang Li, Timothy F Porter, Fabien Loison, Bara Sarraj, Anongnard Kasorn, Hakryul Jo and 6 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 95 papers.

0numbers the graph read from it
0cells of the map it votes in
95citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

95 citing papers in PubMed, 160 citations in OpenAlex.

  1. Dirhamnolipids fromACS omega · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Humanization of CD47 enables development of functional human neutrophils via postirradiation remodeling of the bone marrow.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. Article
  8. Review
  9. Role of TRPV1Inflammopharmacology · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Survival Factor A (SvfA) Contributes toJournal of fungi (Basel, Switzerland) · 2023
    Article
  19. Review
  20. Article

35 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Hidenori HattoriDepartment of Pathology, Harvard Medical School, Boston, MA 02115, USA.
Kulandayan K Subramanian
Jiro Sakai
Yonghui Jia
Yitang Li
Timothy F Porter
Fabien Loison
Bara Sarraj
Anongnard Kasorn
Hakryul Jo
Catlyn Blanchard
Dorothy Zirkle
Douglas McDonald
Sung-Yun Pai
Charles N Serhan
Hongbo R Luo
Harvard University · USDana-Farber/Harvard Cancer Center · USBoston Children's Hospital · USBrigham and Women's Hospital · US

Funding

TRANSFUSION BIOLOGY AND MEDICINET32HL066987 · NHLBI · CHILDREN'S HOSPITAL BOSTON · PI JOHN P MANIS · 2001 to 2026
$10.2M
Enhancing neutrophil function in neutropenia-related pneumoniaR01HL092020 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI LUO, HONGBO R · 2009 to 2022
$5.2M
Molecular basis of neutrophil spontaneous deathR01HL085100 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI LUO, HONGBO R · 2007 to 2010
$2.0M
HTS for enhancers of neutrophil function that specifically augment PIP3 signalR01AI076471 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI LUO, HONGBO R · 2009 to 2012
$1.5M
Signal transduction in neutrophil chemotaxisR01GM076084 · NIGMS · BOSTON CHILDREN'S HOSPITAL · PI LUO, HONGBO R · 2006 to 2010
$1.5M
NHLBI NIH HHS HL066987NHLBI NIH HHS HL085100NHLBI NIH HHS HL092020NHLBI NIH HHS R01 HL085100NHLBI NIH HHS R01 HL092020NHLBI NIH HHS T32 HL066987NIAID NIH HHS AI076471NIAID NIH HHS R01 AI076471NIGMS NIH HHS GM076084NIGMS NIH HHS R01 GM076084
6 · The paper itself

Abstract

Neutrophil chemotaxis plays an essential role in innate immunity, but the underlying cellular mechanism is still not fully characterized. Here, using a small-molecule functional screening, we identified NADPH oxidase-dependent reactive oxygen species as key regulators of neutrophil chemotactic migration. Neutrophils with pharmacologically inhibited oxidase, or isolated from chronic granulomatous disease (CGD) patients and mice, formed more frequent multiple pseudopodia and lost their directionality as they migrated up a chemoattractant concentration gradient. Knocking down NADPH oxidase in differentiated neutrophil-like HL60 cells also led to defective chemotaxis. Consistent with the in vitro results, adoptively transferred CGD murine neutrophils showed impaired in vivo recruitment to sites of inflammation. Together, these results present a physiological role for reactive oxygen species in regulating neutrophil functions and shed light on the pathogenesis of CGD.

Indexed as

ChemotaxisSmall Molecule LibrariesAnimalsDrug Evaluation, PreclinicalGene Knockdown TechniquesGranulomatous Disease, ChronicHL-60 CellsHumansMiceMice, Inbred StrainsNADPH OxidasesNeutrophilsReactive Oxygen SpeciesNADPH OxidasesReactive Oxygen SpeciesSmall Molecule Libraries

Identifiers

PMID20142487
PMCPMC2840460
OpenAlexW1984228225

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.